Target Audience and Goal Statement
This educational activity is intended for an international audience of non-US healthcare professionals, specifically interventional
cardiologists, general cardiologists, emergency department physicians, internists, and primary care physicians involved in
the management of patients with acute coronary syndromes (ACS).
The goal of this activity is to apply the current European Society of Cardiology guidelines for the use of dual antiplatelet
therapy for the secondary prevention of myocardial infarction and the use of evidence-based therapies for comorbid cardiovascular
(CV) disease with the goal of improving the clinical care of patients with ACS.
Upon completion of this activity, participants will be able to:
- Apply the current treatment practice guidelines for the prevention of recurrent CV events following myocardial infarction
- Evaluate the accumulated evidence, including late-breaking data, demonstrating the benefit of dual antiplatelet therapy for
the prevention of recurrent CV events
Disclosures
In compliance with EBAC/EACCME guidelines, all speakers/chairpersons participating in this programme have disclosed potential
conflicts of interest that might cause a bias in the presentations. The Organising Committee is responsible for ensuring that
all potential conflicts of interest relevant to the programme are declared to the audience prior to the CME activities.
Faculty
-
Robert F. Storey, BSc, BM, MRCP, DM
Professor of Cardiology, Department of Cardiovascular Science, University of Sheffield; Academic Director and Honorary Consultant
in Cardiology, The Cardiology and Cardiothoracic Surgery Directorate, Sheffield Teaching Hospitals, Sheffield, United Kingdom
Disclosures
Disclosure: Robert F. Storey, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Aspen; AstraZeneca Pharmaceuticals LP; Correvio International; The Medicines Company;
Thermo Fisher Scientific Inc.; PlaqueTec Ltd.
Served as a speaker or a member of a speakers bureau for: Accumetrics, Inc.; AstraZeneca Pharmaceuticals LP
Received grants for clinical research from: Accumetrics, Inc.; AstraZeneca Pharmaceuticals LP; Merck & Co., Inc.
Other: Listed as inventor on patent application related to Pegasus-TIMI 54 results (no financial interest) for AstraZeneca
Pharmaceuticals, LP
Steering Committee
-
Keith A. A. Fox, MD
Disclosures
Disclosure: Keith A. A. Fox, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: AstraZeneca Pharmaceuticals, LP; Bayer HealthCare Pharmaceuticals; Janssen Pharmaceuticals,
Inc.; Eli Lilly and Company; Sanofi
Served as a speaker or a member of a speakers bureau for: AstraZeneca Pharmaceuticals, LP; Bayer HealthCare Pharmaceuticals;
Janssen Pharmaceuticals, Inc.; Sanofi
Received grants for clinical research from: AstraZeneca Pharmaceuticals, LP; Bayer HealthCare Pharmaceuticals; Janssen Pharmaceuticals,
Inc.; Eli Lilly and Company; Sanofi
-
Héctor Bueno, MD, PhD
Disclosures
Disclosure: Héctor Bueno, MD, PhD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: AstraZeneca Pharmaceuticals, LP; Bayer HealthCare Pharmaceuticals; Daiichi Sankyo,
Inc.; Eli Lilly and Company; Novartis Pharmaceuticals Corporation
Served as a speaker or a member of a speakers bureau for: AstraZeneca Pharmaceuticals, LP; Bayer HealthCare Pharmaceuticals;
Daiichi Sankyo, Inc.; Eli Lilly and Company; Novartis Pharmaceuticals Corporation
Received grants for clinical research from: AstraZeneca Pharmaceuticals, LP
-
Timm Bauer, MD
Disclosures
Disclosure: Timm Bauer, MD, has disclosed the following relevant financial relationships:
Served as a speaker or a member of a speakers bureau for: Abbott Cardiovascular Systems, Inc.; AstraZeneca Pharmaceuticals
LP; Bayer AG; Berlin-Chemie AG; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; Gore Medical
-
Derek P. Chew, MBBS, MPH, FRACP
Disclosures
Disclosure: Derek P. Chew, MBBS, MPH, FRACP, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Abbott Laboratories
Served as a speaker or a member of a speakers bureau for: AstraZeneca Pharmaceuticals, LP
Received grants for clinical research from: Abbott Laboratories
-
José C. Nicolau, MD, PhD
Disclosures
Disclosure: José C. Nicolau, MD, PhD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: AstraZeneca Pharmaceuticals, LP; Bayer HealthCare Pharmaceuticals; Sanofi; Merck Sharp
& Dohme Corp.
Served as a speaker or a member of a speakers bureau for: AstraZeneca Pharmaceuticals, LP; Bayer HealthCare Pharmaceuticals;
Daiichi Sankyo, Inc.; Sanofi
Received grants for clinical research from: Amgen Inc.; AstraZeneca Pharmaceuticals, LP; GlaxoSmithKline; Merck Sharp & Dohme
Corp.; Novartis Pharmaceuticals Corporation; Sanofi
-
P. Gabriel Steg, MD
Disclosures
Disclosure: P. Gabriel Steg, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Amarin Corporation plc; AstraZeneca Pharmaceuticals, LP; Bayer HealthCare Pharmaceuticals;
Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; Daiichi Sankyo, Inc.; GlaxoSmithKline; Lilly; Medtronic,
Inc.; Otsuka Pharmaceutical Co., Ltd.; Pfizer Inc; Roche; Sanofi; SERVIER; Takeda Pharmaceuticals North America, Inc.; The
Medicines Company; VIVUS Inc.
Received grants for clinical research from: Sanofi; SERVIER
Owns stock, stock options, or bonds from: Aterovax
Editors
Content Reviewer
Accreditation Statements
For Physicians
-
The Internet Course “Preventing Recurrent CV Events: Role of Antithrombotic Therapy” is accredited by the European Board for Accreditation in Cardiology (EBAC) for 1.00 hours of External CME credits.
Each participant should claim only those hours of credit that have actually been spent in the educational activity. EBAC
works according to the quality standards of the European Accreditation Council for Continuing Medical Education (EACCME),
which is an institution of the European Union of Medical Specialists (UEMS).
Contact This Provider
For questions regarding the content of this activity, contact the
accredited provider for this CME/CE activity noted above. For technical
assistance, contact [email protected]
Instructions for Participation and Credit
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page.
Follow these steps to earn CME/CE credit*:
- Read the target audience, learning objectives, and author disclosures.
- Study the educational content online or printed out.
- Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated
at the top of the test. Medscape Education encourages you to complete the Activity Evaluation to provide feedback for future
programming.
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print
out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.
*The credit that you receive is based on your user profile.
